Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)

4.11
Delayed Data
As of 3:59pm ET
 -0.03 / -0.72%
Today’s Change
2.85
Today|||52-Week Range
9.40
-12.57%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization50.0K43.0K18.0K16.0K
 
 
 
 
 
 
Operating ExpensesGross Income-50.0K-43.0K-18.0K-16.0K
 
 
 
 
 
General Expenses7.6M7.5M5.1M4.8M
 
 
 
 
 
Research And Development5.5M4.9M3.0M2.8M
 
 
 
 
 
Total Operating Expenses7.6M7.5M5.1M4.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.6M-7.5M-5.1M-4.8M
 
 
 
 
 
Extraordinary Credit16.0K11.0K6.0K0.00
 
 
 
 
Other Expenses15.0K17.0K21.0K42.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.6M-7.5M-5.1M-4.8M
 
 
 
 
 
Net Income-7.6M-7.5M-5.1M-4.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.6M3.9M4.0M7.3M
 
 
 
 
 
Shares To Calculate EPS Diluted2.6M3.9M4.0M7.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.90---$1.27-$0.65
 
 
 
 
EPS Diluted-$2.90-$2.00-$1.27-$0.65